文献速递神经肿瘤

颅内脑膜瘤大分割立体定向放疗的长期结局与症状反应

Long-Term Outcomes and Symptom Response Following Hypofractionated Stereotactic Radiotherapy for Intracranial Meningioma.
PubMed 文献 · World Neurosurg · 2026-05-12

本研究回顾性分析了92例接受5次大分割立体定向放疗的良性脑膜瘤患者,中位随访28个月,1年、3年、5年局部控制率分别为98%、93%、87%,58%患者症状部分改善或消失,18%出现G1或G2毒性。

要点

  • 5次25Gy的大分割立体定向放疗对良性脑膜瘤可实现良好的局部控制与安全性。
  • 58%的患者在放疗后症状部分改善或完全缓解。
  • 排除既往放疗患者后,1、3、5年局部控制率提高至99%、97%、94%。

核心结论

  • 5次25Gy的大分割立体定向放疗方案对良性脑膜瘤可有效实现局部控制且安全性良好。

主要发现

  • 中位随访28个月,1年、3年、5年局部控制率分别为98%、93%、87%。
  • 排除既往接受放疗的患者后,亚组分析显示1年、3年、5年局部控制率分别为99%、97%、94%。
  • 按肿瘤大小分类后卡方分析显示失败率无差异(χ2=0.6,P=0.73)。

关键数值与推荐

  • 放疗方案为25 Gy分5次。
  • 局部控制率:1年98%、3年93%、5年87%(全体分析人群)。
  • 亚组(排除既往放疗)局部控制率:1年99%、3年97%、5年94%。

临床怎么用

  • 对于良性脑膜瘤,可考虑采用5次25Gy的大分割立体定向放疗方案,该方案在所选患者中显示出良好的局部控制和可接受的毒性。

局限性

  • 本研究为回顾性设计,样本量有限,中位随访时间较短。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Various radiation dosing regimens exist due to tumor size, location, and patient preference. This study evaluated the long-term outcomes of patients with benign meningiomas treated with hypofractionated stereotactic radiotherapy (SRT)at our institution. METHODS: This is a retrospective review of all patients diagnosed with meningioma at our institution who received hypofractionated SRT (5 fractions). Clinical data, including tumor location, size, prior treatments, demographics, radiation dosimetric information, tumor response, and survival were collected. Kaplan-Meier curves were used to assess local control (LC). Acute and late toxicities were evaluated. Patients were included for analysis if they had at least one post-treatment magnetic resonance imaging following therapy. RESULTS: One hundred-eight patients with benign meningiomas treated between 2013 and 2022 were identified, with 92 included for analysis (n = 16 excluded due to lack of follow-up). With median follow-up of 28 months, the 1-year, 3-year, and 5-year LC rates were 98%, 93%, and 87%, respectively. Fifty-three (58%) patients had partial improvement or resolution of presenting symptoms after completing radiation treatment. When conducting a subgroup analysis excluding patients previously treated with radiation, LC improved to 99%, 97%, and 94% at 1, 3, and 5 years, respectively. Seventeen patients (18%) had G1 or G2 toxicities, with 3 of them experiencing G2 radionecrosis. Tumors were categorized by size and Chi-squared analysis showed no difference in the rate of failure (χ2 = 0.6, P = 0.73). CONCLUSIONS: The SRT regimen of 25 Gy in 5 fractions effectively achieves LC and safety in benign meningiomas. These findings highlight the need for further clinical studies to better understand World Health Organization grade 1 meningiomas.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Shah R, Haldar N, Jain S, et al. Long-Term Outcomes and Symptom Response Following Hypofractionated Stereotactic Radiotherapy for Intracranial Meningioma. World Neurosurg. 2026. PMID: 42128342. doi:10.1016/j.wneu.2026.125045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。